{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T02:11:06Z","timestamp":1762999866835},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,30]]},"DOI":"10.7759\/cureus.70552","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T19:11:37Z","timestamp":1727723497000},"source":"Crossref","is-referenced-by-count":1,"title":["Complications of Long COVID: Unraveling a Case of Very-Late-Onset Myasthenia Gravis"],"prefix":"10.7759","author":[{"given":"Hamid","family":"Feiz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Courteney","family":"Castellano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leyla","family":"Feiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-019-0079-y","article-title":"Myasthenia gravis","volume":"5","author":"Gilhus NE","year":"2019","unstructured":"Gilhus NE, Tzartos S, Evoli A, Palace J, Burns TM, Verschuuren JJ. Myasthenia gravis. Nat Rev Dis Primers. 2019, 5:30. 10.1038\/s41572-019-0079-y","journal-title":"Nat Rev Dis Primers"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.843523","article-title":"Efficacy and safety of tacrolimus therapy for a single Chinese cohort with very-late-onset myasthenia gravis","volume":"13","author":"Zheng Y","year":"2022","unstructured":"Zheng Y, Yuan X, Zhang C, et al.. Efficacy and safety of tacrolimus therapy for a single Chinese cohort with very-late-onset myasthenia gravis. Front Neurol. 2022, 13:23. 10.3389\/fneur.2022.843523","journal-title":"Front Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s41983-022-00516-3","article-title":"The relationship between myasthenia gravis and COVID-19: a systematic review","volume":"58","author":"Tugasworo D","year":"2022","unstructured":"Tugasworo D, Kurnianto A, Retnaningsih, Andhitara Y, Ardhini R, Budiman J. The relationship between myasthenia gravis and COVID-19: a systematic review. Egypt J Neurol Psychiatr Neurosurg. 2022, 58:83. 10.1186\/s41983-022-00516-3","journal-title":"Egypt J Neurol Psychiatr Neurosurg"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.33048","article-title":"A case report and literature review of new-onset myasthenia gravis after COVID-19 infection","volume":"14","author":"Chatterjee T","year":"2022","unstructured":"Chatterjee T, Senthil Kumaran S, Roy M. A case report and literature review of new-onset myasthenia gravis after COVID-19 infection. Cureus. 2022, 14:48. 10.7759\/cureus.33048","journal-title":"Cureus"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-10263-1","article-title":"New onset of ocular myasthenia gravis in a patient with COVID-19: a novel case report and literature review","volume":"268","author":"Sriwastava S","year":"2021","unstructured":"Sriwastava S, Tandon M, Kataria S, Daimee M, Sultan S. New onset of ocular myasthenia gravis in a patient with COVID-19: a novel case report and literature review. J Neurol. 2021, 268:2690-6. 10.1007\/s00415-020-10263-1","journal-title":"J Neurol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1602678","article-title":"Myasthenia gravis","volume":"375","author":"Gilhus NE","year":"2016","unstructured":"Gilhus NE. Myasthenia gravis. N Engl J Med. 2016, 375:2570-81. 10.1056\/NEJMra1602678","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27369","article-title":"Clinical profile and impact of comorbidities in patients with very-late-onset myasthenia gravis","volume":"64","author":"Vijayan J","year":"2021","unstructured":"Vijayan J, Menon D, Barnett C, Katzberg H, Lovblom LE, Bril V. Clinical profile and impact of comorbidities in patients with very-late-onset myasthenia gravis. Muscle Nerve. 2021, 64:462-6. 10.1002\/mus.27369","journal-title":"Muscle Nerve"},{"key":"ref8","unstructured":"Long COVID Basics. (2024). Accessed. April 2024: https:\/\/www.cdc.gov\/covid\/long-term-effects\/index.html."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01499-2021","article-title":"ERS\/ATS technical standard on interpretive strategies for routine lung function tests","volume":"60","author":"Stanojevic S","year":"2022","unstructured":"Stanojevic S, Kaminsky DA, Miller MR, et al.. ERS\/ATS technical standard on interpretive strategies for routine lung function tests. Eur Respir J. 2022, 60:21. 10.1183\/13993003.01499-2021","journal-title":"Eur Respir J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/ene.14721","article-title":"Myasthenia gravis associated with anti-MuSK antibodies developed after SARS-CoV-2 infection","volume":"28","author":"Assini A","year":"2021","unstructured":"Assini A, Gandoglia I, Damato V, Rikani K, Evoli A, Del Sette M. Myasthenia gravis associated with anti-MuSK antibodies developed after SARS-CoV-2 infection. Eur J Neurol. 2021, 28:3537-9. 10.1111\/ene.14721","journal-title":"Eur J Neurol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijscr.2021.105771","article-title":"Management of thymomatous myasthenia gravis - case report of a rare COVID19 infection sequelae","volume":"81","author":"Bhandarwar A","year":"2021","unstructured":"Bhandarwar A, Jadhav S, Tandur A, Dhimole N, Wagh A, Bhondve S. Management of thymomatous myasthenia gravis - case report of a rare COVID19 infection sequelae. Int J Surg Case Rep. 2021, 81:71. 10.1016\/j.ijscr.2021.105771","journal-title":"Int J Surg Case Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-244102","article-title":"Transient acetylcholine receptor-related myasthenia gravis, post multisystem inflammatory syndrome in children (MIS-C) temporally associated with COVID-19 infection","volume":"14","author":"Essajee F","year":"2021","unstructured":"Essajee F, Lishman J, Solomons R, Abraham DR, Goussard P, Van Toorn R. Transient acetylcholine receptor-related myasthenia gravis, post multisystem inflammatory syndrome in children (MIS-C) temporally associated with COVID-19 infection. BMJ Case Rep. 2021, 14:2. 10.1136\/bcr-2021-244102","journal-title":"BMJ Case Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.576153","article-title":"Postinfectious onset of myasthenia gravis in a COVID-19 patient","volume":"11","author":"Huber M","year":"2020","unstructured":"Huber M, Rogozinski S, Puppe W, Framme C, H\u00f6glinger G, Hufendiek K, Wegner F. Postinfectious onset of myasthenia gravis in a COVID-19 patient. Front Neurol. 2020, 11:53. 10.3389\/fneur.2020.576153","journal-title":"Front Neurol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/covid2040033","article-title":"New onset generalized myasthenia gravis evolving following SARS-CoV-2 infection","volume":"2","author":"J\u00f5gi K","year":"2022","unstructured":"J\u00f5gi K, Sabre L, Rosental M, Leheste AR, Vilisaar J. New onset generalized myasthenia gravis evolving following SARS-CoV-2 infection. COVID. 2022, 2:464-71. 10.3390\/covid2040033","journal-title":"COVID"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2021.106834","article-title":"Myasthenia gravis associated with novel coronavirus 2019 infection: a report of three cases","volume":"208","author":"Karimi N","year":"2021","unstructured":"Karimi N, Okhovat AA, Ziaadini B, Haghi Ashtiani B, Nafissi S, Fatehi F. Myasthenia gravis associated with novel coronavirus 2019 infection: a report of three cases. Clin Neurol Neurosurg. 2021, 208:34. 10.1016\/j.clineuro.2021.106834","journal-title":"Clin Neurol Neurosurg"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.7326\/L20-1298","article-title":"MuSK antibody-associated myasthenia gravis With SARS-CoV-2 infection: a case report","volume":"174","author":"Muhammed L","year":"2021","unstructured":"Muhammed L, Baheerathan A, Cao M, Leite MI, Viegas S. MuSK antibody-associated myasthenia gravis With SARS-CoV-2 infection: a case report. Ann Intern Med. 2021, 174:872-3. 10.7326\/L20-1298","journal-title":"Ann Intern Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-244146","article-title":"Temporal association between SARS-CoV-2 and new-onset myasthenia gravis: is it causal or coincidental?","volume":"14","author":"Muralidhar Reddy Y","year":"2021","unstructured":"Muralidhar Reddy Y, B SK, Osman S, Murthy JM. Temporal association between SARS-CoV-2 and new-onset myasthenia gravis: is it causal or coincidental?. BMJ Case Rep. 2021, 14:46. 10.1136\/bcr-2021-244146","journal-title":"BMJ Case Rep"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.nrleng.2020.04.003","article-title":"SARS-CoV-2 infection associated with diplopia and anti-acetylcholine receptor antibodies","volume":"35","author":"P\u00e9rez \u00c1lvarez \u00c1I","year":"2020","unstructured":"P\u00e9rez \u00c1lvarez \u00c1I, Su\u00e1rez Cuervo C, Fern\u00e1ndez Men\u00e9ndez S. SARS-CoV-2 infection associated with diplopia and anti-acetylcholine receptor antibodies. Neurolog\u00eda. 2020, 35:264-5. 10.1016\/j.nrleng.2020.04.003","journal-title":"Neurolog\u00eda"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.7326\/L20-0845","article-title":"Myasthenia gravis associated with SARS-CoV-2 infection","volume":"173","author":"Restivo DA","year":"2020","unstructured":"Restivo DA, Centonze D, Alesina A, Marchese-Ragona R. Myasthenia gravis associated with SARS-CoV-2 infection. Ann Intern Med. 2020, 173:1027-8. 10.7326\/L20-0845","journal-title":"Ann Intern Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/rcr2.978","article-title":"New-onset myasthenia gravis after novel coronavirus 2019 infection","volume":"10","author":"Taheri A","year":"2022","unstructured":"Taheri A, Davoodi L, Soleymani E, Ahmadi N. New-onset myasthenia gravis after novel coronavirus 2019 infection. Respirol Case Rep. 2022, 10:e0978. 10.1002\/rcr2.978","journal-title":"Respirol Case Rep"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26990","article-title":"A brief review of influenza virus infection","volume":"93","author":"Javanian M","year":"2021","unstructured":"Javanian M, Barary M, Ghebrehewet S, Koppolu V, Vasigala V, Ebrahimpour S. A brief review of influenza virus infection. J Med Virol. 2021, 93:4638-46. 10.1002\/jmv.26990","journal-title":"J Med Virol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-018-8751-9","article-title":"Myasthenia gravis and infectious disease","volume":"265","author":"Gilhus NE","year":"2018","unstructured":"Gilhus NE, Romi F, Hong Y, Skeie GO. Myasthenia gravis and infectious disease. J Neurol. 2018, 265:1251-8. 10.1007\/s00415-018-8751-9","journal-title":"J Neurol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22522","article-title":"Lack of evidence for Epstein-Barr virus infection in myasthenia gravis thymus","volume":"70","author":"Meyer M","year":"2011","unstructured":"Meyer M, H\u00f6ls AK, Liersch B, et al.. Lack of evidence for Epstein-Barr virus infection in myasthenia gravis thymus. Ann Neurol. 2011, 70:515-8. 10.1002\/ana.22522","journal-title":"Ann Neurol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-021-05823-w","article-title":"Myasthenia gravis exacerbation and myasthenic crisis associated with COVID-19: case series and literature review","volume":"43","author":"Rodrigues CL","year":"2022","unstructured":"Rodrigues CL, de Freitas HC, Lima PR, de Oliveira Junior PH, Fernandes JM, D'Almeida JA, N\u00f3brega PR. Myasthenia gravis exacerbation and myasthenic crisis associated with COVID-19: case series and literature review. Neurol Sci. 2022, 43:2271-6. 10.1007\/s10072-021-05823-w","journal-title":"Neurol Sci"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21902","article-title":"Epstein-Barr virus persistence and reactivation in myasthenia gravis thymus","volume":"67","author":"Cavalcante P","year":"2010","unstructured":"Cavalcante P, Serafini B, Rosicarelli B, et al.. Epstein-Barr virus persistence and reactivation in myasthenia gravis thymus. Ann Neurol. 2010, 67:726-38. 10.1002\/ana.21902","journal-title":"Ann Neurol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph20010467","article-title":"COVID-19 vaccination and late-onset myasthenia gravis: A new case report and review of the literature","volume":"20","author":"Virgilio E","year":"2022","unstructured":"Virgilio E, Tondo G, Montabone C, Comi C. COVID-19 vaccination and late-onset myasthenia gravis: A new case report and review of the literature. Int J Environ Res Public Health. 2022, 20:67. 10.3390\/ijerph20010467","journal-title":"Int J Environ Res Public Health"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12185983","article-title":"Efficacy and safety of intravenous immunoglobulin treatment in selected neurological diseases\u2014one centre\u2019s experience based on the therapy of 141 patients","volume":"12","author":"Lasek-Bal A","year":"2023","unstructured":"Lasek-Bal A, Wagner-Kusz A, Rogo\u017c B, Cisowska-Babraj M, Gajewska G. Efficacy and safety of intravenous immunoglobulin treatment in selected neurological diseases\u2014one centre\u2019s experience based on the therapy of 141 patients. J Clin Med. 2023, 12:83. 10.3390\/jcm12185983","journal-title":"J Clin Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/280479-complications-of-long-covid-unraveling-a-case-of-very-late-onset-myasthenia-gravis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T19:11:40Z","timestamp":1727723500000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/280479-complications-of-long-covid-unraveling-a-case-of-very-late-onset-myasthenia-gravis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,30]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.70552","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,30]]}}}